Amyris Inc. Investor Presentation September 2020

Amyris is a synthetic biology company with a portfolio of platform molecules for clean beauty, functional ingredients, and health & wellness applications. The company demonstrated 140% sales growth from FY2018 to FY2019 and reported 56% gross margin, driven by consumer megatrends and proprietary science-enabled partnerships.